Abstract
Objective
To call attention to the worldwide increase in tuberculosis and to review the disease in peritoneal dialysis patients.
Data Sources
Recent epidemiological publications.
Data Extraction
Epidemiological data summarized in tables and diagnostic and therapeutic recommendations reviewed.
Conclusions
Tuberculosis is on the rise worldwide. Multiple drug-resistant strains are emerging, causing therapeutic problems. The role of atypical mycobacterial infections in continuous ambulatory peritoneal dialysis (CAPD) is reviewed. Early diagnosis of cases and thorough chemotherapy are advocated.
Get full access to this article
View all access options for this article.
